Search company, investor...
Search

Predict your next investment

Corporate Venture

See what CB Insights has to offer

Investments

6

Funds

1

About Colorcon Ventures

Colorcon Ventures is the venture arm of specialty ingredients firm Colorcon focused on investing in startups that are strategically relevant to the core Colorcon business.

Colorcon Ventures Headquarters Location

Harleysville, Pennsylvania, 19438,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Colorcon Ventures News

08:00 EDT Colorcon Ventures Invests in Novome Biotechnologies, an Engineered Microbial Therapy Company

Sep 15, 2022

News provided by Share this article Innovative platform to enable oral delivery of biologics for the treatment of chronic diseases HARLEYSVILLE, Pa., Sept. 15, 2022 /CNW/ -- Colorcon Ventures, the corporate venture fund of Colorcon Inc., has invested in Novome Biotechnologies, a clinical-stage company that develops engineered oral microbial therapies. The company's novel delivery platform controls the colonization of therapeutically engineered bacteria, enabling first-in-class treatment of chronic disorders such as inflammatory bowel disease and enteric hyperoxaluria. Ali Rajabi-Siahboomi, Vice President and Chief Innovation Officer at Colorcon, said, "Novome is aligned with Colorcon Ventures' interest in oral delivery of new therapeutic modalities. The company is pioneering a class of oral biologics with an impressive pace of scientific achievement. We look forward to supporting Novome as they realize the full potential of their platform." Blake Wise, Novome's CEO, said, "We are pleased to have the support of Colorcon Ventures as we expand the capabilities of our delivery platform. Colorcon's global relationships and oral formulation expertise will add value to our next phase of growth." Colorcon Ventures joins a prominent list of investors who also participated in Novome's recently announced Series B, including Tencent, DCVC Bio, 5AM Ventures, Alta Partners and Alexandria Venture Investments. About Colorcon Ventures Colorcon Ventures targets investments in transformational solutions for the pharmaceutical and nutraceutical industries across R&D, manufacturing, supply chain, and the delivery of pharmaceutical products and services. Colorcon Ventures is the corporate venture fund of Colorcon Inc., a trusted design and development partner to over 4,500 pharmaceutical companies, around the world, providing expertise to fast-track pharmaceutical formulation and manufacturing. For more information, please visit www.colorcon.com/ventures  or follow @ColorconVC  About Novome Novome Biotechnologies is a clinical-stage biotechnology company developing engineered cellular therapies for the gut to treat chronic diseases. Novome has developed the first platform for the controlled colonization of the gut with engineered bacteria to deliver targeted therapeutic cargos and functions, enabling first-in-class living therapeutics: Genetically Engineered Microbial Medicines (GEMMs). Novome is utilizing its proprietary GEMMs platform in its proof-of-concept program in enteric hyperoxaluria, which is focused on the development of a therapeutic strain of bacteria that degrades oxalate to decrease the risk of kidney stone formation. Significant progress has also been made with earlier-stage programs enabling local delivery of high amounts of therapeutic protein cargo for the potential treatment of inflammatory bowel disease. Efforts are also directed toward advancing additional pipeline indications in irritable bowel syndrome and immuno-oncology. For more information, please visit the Novome Biotechnologies website at https://novomebio.com/

Colorcon Ventures Investments

6 Investments

Colorcon Ventures has made 6 investments. Their latest investment was in Novome Biotechnologies as part of their Series B on September 9, 2022.

CBI Logo

Colorcon Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/13/2022

Series B

Novome Biotechnologies

$43.5M

Yes

4

1/19/2022

Series C

Subscribe to see more

$99M

Subscribe to see more

10

1/6/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

10/13/2021

Series A - II

Subscribe to see more

Subscribe to see more

10

12/3/2020

Seed VC - II

Subscribe to see more

Subscribe to see more

10

Date

9/13/2022

1/19/2022

1/6/2022

10/13/2021

12/3/2020

Round

Series B

Series C

Series A

Series A - II

Seed VC - II

Company

Novome Biotechnologies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$43.5M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

4

10

10

10

10

Colorcon Ventures Fund History

1 Fund History

Colorcon Ventures has 1 fund, including Colorcon Ventures Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

Colorcon Ventures Fund

$50M

1

Closing Date

Fund

Colorcon Ventures Fund

Fund Type

Status

Amount

$50M

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.